+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cumulative effects of risperidone long acting injection and narrative therapy in treating ethanol dependency

      , 1

      Annals of General Psychiatry

      BioMed Central

      1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance

      19–22 November 2009

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Background Aims/objectives: Rationale: Ethanol dependency is among the most frequent psychiatric disorders regardless of age and sex and currently affecting an increasing number of women and children. Its treatment stands on the clinician's decision, family and/or social group support. Our aim is to assess the efficacy of using risperidone long-acting injection along with psychotherapy in gamma type alcohol dependency. Materials and methods Method: Case study. Gathering self-reported data, psychotherapy sessions for the patient and his/her family, data analysis. For relevance purposes we shall present below the case of a 30 yo Caucasian male with a history of alcohol consumption since he was 12 yo. During the past year his alcohol consumption started to follow a daily pattern. The patient's psychopathological presentation is dominated by psychomotor agitation, hypnic disorders, hetero-aggression, interpretative thoughts, depressive ideation, low self-esteem, social, professional and family desinsertion. Following the first four hospital admissions during which he received thymoregulatory, antidepressive and sedative agents his alcohol consumption increased and symptomatology intensified. During his fifth hospital admission the patient received risperidone 2 mg per day, as a neuroleptic agent, followed by risperidone long-acting injection 25 mg once every 2 weeks. After hospital discharge his condition improved incrementally. Two months after hospital release he relapses for two days but is able to cease consumption without external help. The patient is currently professionally and socially active and his family interactions are healthy. Along with risperidone long-acting injection therapy he was admitted to family therapy sessions every week during the first two months, every two weeks for the next two months followed by a monthly session during the next 6 months. Conclusions Using risperidone long-acting injections along with narrative therapy has protracted the abstinence period and has also contributed to social and family reinsertion.

          Related collections

          Author and article information

          Ann Gen Psychiatry
          Annals of General Psychiatry
          BioMed Central
          22 April 2010
          : 9
          : Suppl 1
          : S157
          [1 ]Alexandru Obregia Hospital, Unit 7, Bucharest, Romania
          Copyright ©2009 Trandafir; licensee BioMed Central Ltd.
          1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance
          Thessaloniki, Greece
          19–22 November 2009
          Meeting Abstract

          Clinical Psychology & Psychiatry


          Comment on this article